Midodrine Hydrochloride Milstein

Midodrine Hydrochloride, the active ingredient in Midodrine Hydrochloride Milstein, is an Alpha-1 adrenergic agonist (prodrug) presented as an oral tablet for systemic use. It is prescribed to raise standing blood pressure in adults with orthostatic or neurogenic orthostatic hypotension.

GNH USA supplies Midodrine Hydrochloride Milstein as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU-regulated manufacturers and ensuring quality compliance with EU pharmacopeial standards and reliable global logistics.

Midodrine Hydrochloride is used to treat conditions related to low standing blood pressure within the orthostatic hypotension disease family.

- Orthostatic hypotension: increases standing systolic pressure to reduce dizziness and fainting. - Neurogenic orthostatic hypotension: improves cerebral perfusion in patients with autonomic nervous system failure. - Postural hypotension: helps maintain adequate blood flow when changing from supine to upright position.

Midodrine Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Piloerection (goosebumps) - Itching or skin rash - Urinary retention - Supine hypertension - Nausea - Headache

Serious or Rare Side Effects: - Severe supine hypertension leading to cardiovascular strain - Bradycardia or arrhythmia - Allergic reactions such as angioedema - Myocardial ischemia or infarction

When prescribing Midodrine Hydrochloride, clinicians should observe several safety considerations.

- Monitor blood pressure: check supine and standing values regularly. - Avoid use in patients with severe cardiac disease: risk of excessive hypertension. - Use caution in renal impairment: altered drug clearance may increase effects. - Review concomitant antihypertensives: potential for additive blood pressure changes. - Store at room temperature: keep in the original pack, protect from moisture.

Midodrine Hydrochloride can interact with other medicines, influencing blood pressure control.

Major Interactions (Avoid): - Other alpha‑agonists (e.g., phenylephrine): may cause excessive vasoconstriction. - Monoamine oxidase inhibitors: increase risk of hypertensive crisis. - Central acting antihypertensives (e.g., clonidine): can blunt therapeutic effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may alter blood pressure response. - Calcium channel blockers: require observation for additive hypotensive or hypertensive effects.